Your browser doesn't support javascript.
loading
Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial.
Pivot, Xavier; Cortés, Javier; Lüftner, Diana; Lyman, Gary H; Curigliano, Giuseppe; Bondarenko, Igor M; Ahn, Jin-Hee; Im, Seock-Ah; Litwiniuk, Maria; Shparyk, Yaroslav V; Ho, Gwo Fuang; Kislov, Nikolay V; Wojtukiewicz, Marek; Sarosiek, Tomasz; Chae, Yee Soo; Ahn, Jin Seok; Jang, Hyerin; Kim, Sujung; Lee, Jiwon; Yoon, YeChan.
Afiliación
  • Pivot X; Institut de Cancérologie Strasbourg Europe, Strasbourg, France.
  • Cortés J; International Breast Cancer Center, Pangaea Oncology, Quirónsalud Group, Barcelona, Spain.
  • Lüftner D; Scientific Department, Medica Scientia Innovation Research, Valencia, Spain.
  • Lyman GH; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain.
  • Curigliano G; Campus Rüdersdorf, Immanuel Hospital Märkische Schweiz and Medical University of Brandenburg Theodor Fontane, Rüdersdorf bei Berlin, Germany.
  • Bondarenko IM; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Ahn JH; European Institute of Oncology, IRCCS, University of Milan, Milan, Italy.
  • Im SA; Dnipropetrovsk City Multi-Field Clinical Hospital #4, Dnipropetrovsk, Ukraine.
  • Litwiniuk M; Asan Medical Center, Seoul, Republic of Korea.
  • Shparyk YV; Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.
  • Ho GF; Greater Poland Cancer Centre and Poznan University of Medical Sciences, Poznan, Poland.
  • Kislov NV; Lviv State Oncological Regional Therapeutical and Diagnostic Center, Lviv, Ukraine.
  • Wojtukiewicz M; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
  • Sarosiek T; State Budgetary Healthcare Institution of Yaroslavl Region, Regional Clinical Oncology Hospital, Yaroslavl, Russian Federation.
  • Chae YS; Bialostockie Centrum Onkologii im. Marii Sklodowskiej-Curie, Bialystok, Poland.
  • Ahn JS; LUX MED Onkologia, Warszawa, Poland.
  • Jang H; Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.
  • Kim S; Samsung Medical Center, Seoul, Republic of Korea.
  • Lee J; Samsung Bioepis, Incheon, Republic of Korea.
  • Yoon Y; Samsung Bioepis, Incheon, Republic of Korea.
JAMA Netw Open ; 6(4): e235822, 2023 04 03.
Article en En | MEDLINE | ID: mdl-37022687
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biosimilares Farmacéuticos Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: JAMA Netw Open Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biosimilares Farmacéuticos Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: JAMA Netw Open Año: 2023 Tipo del documento: Article País de afiliación: Francia